Coherent Science Technology International is a specialist skin science and dermatology consultancy helping innovative pharmaceutical and consumer health organisations turn promising ideas into real-world skin health solutions.

We work across the innovation pathway—from pioneering skin sampling and evaluation technologies to designing and delivering ground-breaking early-stage clinical trials internationally. Our approach combines deep scientific and clinical expertise with practical guidance on stakeholder engagement, regulatory and market readiness, and commercial strategy, so projects are built for both scientific success and real-world impact.

With a mission of making healthy skin accessible to all, we are internationally recognised for excellence in skin science and research leadership, and we actively build academia–industry partnerships to accelerate translation from discovery to commercial success.

Coherent Science is led by Professor Tarl Prow—an inventor of minimally invasive skin microbiopsy technology—bringing world-leading expertise across dermatology, skin sampling technologies, biomarker discovery, and related translational disciplines.